Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (696)	3/13/1999 10:46:00 AM
From: Mike McFarland	Respond to of 1073

Any newbies to second and third tier biotech could spend a couple hours studying ImClone this weekend. I noticed McCamant is in the April issue of WORTH magazine with this one again, so he's done a good job of staying on just a few picks and pounding the table. The stock has been jumpy lately, you will find "IMCL", "ImClone" and "McCamant" on a few of the daytrading threads, and I'm sure if anybody out there has a DSL line and runs a bot all day collecting all the noise from the IRC trading channels, you'd find it over there too. Buying and holding what look like cheap third tier stocks has me down 10% for the year at this point--my legs are getting a little wobbly now, and I may have to take my own advice. I'm not saying IMCL is the right one to target...but there may be something to this trading malarkey. After all, when I stopped trading I stopped making money (oh, I know how to lose money trading as well, a lousy purchase of LGNDW at $4 yesterday reminds me how difficult is is to find near term bottoms, Ligand may not be done selling off quite yet). My current picks in order of weight are in my personal profile, note that CTII has moved down the list, I lightened up 5/8ths of my position at 1 3/16, which should make for an excellent by signal--noticed that it immediately went up 1/8 the next day {:-(}

To: scaram(o)uche who wrote (696)	3/14/1999 4:35:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

Fidelity Selects: Biotch 44.72 44.88 27.01 +3.1% Franklin Class A: BioDisA 24.89 27.28 17.68 -0.0% Franklin Class A: GlHlthA 15.19 19.64 12.86 -0.2% AMEX Biotechnology Index. 191.42 +3.0% Dow Jones 30 Industrials. 9,876.35 +1.4% Nasdaq Biotech Index..... 506.01 +7.0% Week after week, quarter after quarter, the story remains the same. Kurt von Emster underperforms. Until recently, he has frequently gone into the public forum (CNBC and others) and blamed the sector. I believe that an honest and courageous person let's the buck stop where it belongs..... at their desk. When he adopts a "cease and desist" policy toward the sector, I will stop posting the piss-poor Franklin/Templeton results. Until then, same time, same station. How can anyone be this bad? Shouldn't sector funds have someone who understands them at the helm? biz.yahoo.com quote.yahoo.com With such loose management, is it any wonder that the corporation as a whole is suffering?